Logo
x

Search

Subscribe Now

Licenses

Bausch + Lomb Licenses US Commercial Rights for Eton Pharmaceuticals' EM-100 to Treat Ocular Itching

Bausch + Lomb Licenses US Commercial Rights for Eton Pharmaceuticals' EM-100 to Treat Ocular Itching

  • February 20, 2019
Arvelle Therapeutics Licenses Exclusive Development & Commercialization Rights for Cenobamate from SK Biopharmaceuticals in EU

Arvelle Therapeutics Licenses Exclusive Development & Commercialization Rights for Cenobamate from SK Biopharmaceuticals in EU

  • February 15, 2019
Recordati Licenses Exclusive Commercialization Rights of Juxtapid (lomitapide) from Aegerion Pharmaceuticals

Recordati Licenses Exclusive Commercialization Rights of Juxtapid (lomitapide) from Aegerion Pharmaceuticals

  • February 7, 2019
Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

  • January 18, 2019
Sanofi Licenses Biomunex Pharmaceuticals' BiXAb Technology to Develop Bi- and Multi-Specific Antibodies

Sanofi Licenses Biomunex Pharmaceuticals' BiXAb Technology to Develop Bi- and Multi-Specific Antibodies

  • January 16, 2019
Chiesi Farmaceutici Licenses Tum Bio's NCE401 for $74M

Chiesi Farmaceutici Licenses Tum Bio's NCE401 for $74M

  • January 14, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.